333 related articles for article (PubMed ID: 6721513)
21. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse.
Nicolini A; Caciagli M; Zampieri F; Ciampalini G; Carpi A; Spisni R; Colizzi C
Cancer Detect Prev; 1995; 19(2):183-95. PubMed ID: 7750106
[TBL] [Abstract][Full Text] [Related]
22. [Tissue polypeptide antigen in serum and tissue in patients with lung cancer].
Haga E
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Apr; 28(4):595-604. PubMed ID: 2170727
[TBL] [Abstract][Full Text] [Related]
23. [Distribution and prognostic value of CEA and TPA in cancer of the lung].
Leonardo E; Dogliotti C; Mancuso M; Sanfilippo B; Oliaro A
Minerva Med; 1986 Mar; 77(11):375-9. PubMed ID: 3703330
[TBL] [Abstract][Full Text] [Related]
24. [Clinical significances of tissue polypeptide antigen in patients with gynecological malignancies].
Ueda M; Sudo N; Furuya M; Arakawa O; Ikarashi T
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2361-8. PubMed ID: 3001201
[TBL] [Abstract][Full Text] [Related]
25. [Clinical evaluation of six tumor markers (ferritin, CEA, TPA, AFP, PAP, gamma-Sm) in serum in patients with urogenital malignancies].
Koizumi F; Nakamura E; Kawamura T; Ishimori A; Hoshi S; Matsuda S
Rinsho Byori; 1986 Sep; 34(9):1053-8. PubMed ID: 2432295
[No Abstract] [Full Text] [Related]
26. Tissue polypeptide antigen and carcinoembryonic antigen in colon tumors: serum levels and immunohistochemical localization.
Bombardieri E; Jotti GS; Cocciolo MG; Mori M; Rusconi A; Rusca M; Seregni E; Becchi G; Fontanesi M; Tardini A
Cancer Detect Prev; 1985; 8(1-2):219-26. PubMed ID: 4064041
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of different serum tumor markers in gynecological malignancies.
Paulick R; Caffier H; Horner G; Lang K; Filbry E
Cancer Detect Prev; 1985; 8(1-2):115-20. PubMed ID: 4064031
[TBL] [Abstract][Full Text] [Related]
28. [Clinical utility of tumor markers in gastric and colon cancer].
Ogawa K; Naritaka Y; Koyama N; Ohtani Y; Kawata H; Yagawa H; Kajiwara T; Sakakibara N
Gan No Rinsho; 1985 May; 31(6 Suppl):638-47. PubMed ID: 3861884
[TBL] [Abstract][Full Text] [Related]
29. [Clinical study on tissue polypeptide antigen (TPA) as a tumor marker].
Kanauchi M; Sawai F; Saito T; Yumura F; Kanauchi K; Hamaguchi T; Hara Y; Yoshimura K; Nishiura K; Dohi K
Gan No Rinsho; 1984 Mar; 30(3):265-71. PubMed ID: 6201629
[TBL] [Abstract][Full Text] [Related]
30. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
[TBL] [Abstract][Full Text] [Related]
31. [The tumor markers CEA, TPA and CA 19-9 and ferritin and osteocalcin in follow-up studies in breast cancer].
Schatz C; von Lieven H; Mulders M; Rowold J; Stracke H; Müller H; Grebe SF; Schatz H
Wien Klin Wochenschr; 1985 Dec; 97(23):873-9. PubMed ID: 3878042
[TBL] [Abstract][Full Text] [Related]
32. [The tumor markers TPA and CEA in the after care of breast cancer].
Beaufort F; Fueger GF; Steiner H
Wien Med Wochenschr; 1985 Feb; 135(4):85-8. PubMed ID: 2986366
[TBL] [Abstract][Full Text] [Related]
33. Comparison of serum CEA, PHI, and TPA as tumor markers in breast cancer patients.
Paulick R; Caffier H; Paulick M
Cancer Detect Prev; 1987; 10(3-4):197-203. PubMed ID: 3568016
[TBL] [Abstract][Full Text] [Related]
34. Significance of carcinoembryonic and tissue polypeptide antigen determination in the diagnosis of metastases in breast cancer.
Kausitz J; Hupka S; Makaiová I; Michalíková B; Urbanová M; Bohunický L; Belovicová C
Neoplasma; 1986; 33(4):471-6. PubMed ID: 3762808
[TBL] [Abstract][Full Text] [Related]
35. Serum tumor markers in colorectal cancer staging, grading, and follow-up.
Plebani M; De Paoli M; Basso D; Roveroni G; Giacomini A; Galeotti F; Corsini A
J Surg Oncol; 1996 Aug; 62(4):239-44. PubMed ID: 8691835
[TBL] [Abstract][Full Text] [Related]
36. [Measurement of serum tissue polypeptide antigen (TPA) in patients with malignant tumor using prolifigen TPA-M "Daiichi" kit].
Sakahara H; Endo K; Torizuka K; Itoh K; Ohuchi N; Inaba N; Miyaji Y; Takayama M; Ishii K; Takagi H; Konishi J; Fukuoka M; Fukuchi M; Ohkawa J; Kagawa S; Kondo S; Shirouzu K; Iguchi H
Gan To Kagaku Ryoho; 1996 May; 23(6):733-43. PubMed ID: 8645025
[TBL] [Abstract][Full Text] [Related]
37. [CEA, GICA, TPA, fibrinopeptide-A, gamma-GT and gastric cancer. A contribution to the rationalization of a combined assay].
Abbasciano V; Graziano L; Arcudi D; Tassinari D; Nielsen I; Sartori S
Recenti Prog Med; 1991 Oct; 82(10):517-9. PubMed ID: 1684676
[TBL] [Abstract][Full Text] [Related]
38. [A study on tumor marker of tissue-polypeptide-antigen (TPA) in gynecologic malignancies].
Nakajima H; Hirata T; Norisugi T; Furuno K; Ikehata N; Utsunomiya A; Kobayashi K; Negishi Y; Akiya K
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Oct; 36(10):1877-83. PubMed ID: 6094688
[TBL] [Abstract][Full Text] [Related]
39. The cancer associated antigen test as an index to failure of complete removal of urological cancers.
Wechsler M; Lo Gerfo P; Feminella J; Lattimer JK
Trans Am Assoc Genitourin Surg; 1972; 64():85-7. PubMed ID: 4347503
[No Abstract] [Full Text] [Related]
40. Serum tumor markers in metastatic breast cancer and course of disease.
Caffier H; Brandau H
Cancer Detect Prev; 1983; 6(4-5):451-7. PubMed ID: 6197167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
